Skip to main content
SpringerLink
Log in

Indications for Sublobar Resection in the Treatment of Non-Small Cell Lung Cancer (NSCLC)

  • Chapter
Video-Atlas of VATS Pulmonary Sublobar Resections

  • 257 Accesses

Abstract

Implementation of lung cancer screening leads to an increasing number of patients with early-stage non-small cell lung cancer at diagnosis, and also a greater proportion of ground glass/lepidic cancers which manifest more indolent behavior compared to solid tumors. Similarly, there is an increasing population of older patients with comorbidities who are diagnosed in earlier tumor stages. These factors draw attention to the question whether segmentectomy is an alternative to the traditional standard of lobectomy for early-stage lung cancer. This chapter reviews the current evidence regarding this question—specifically either as an elective alternative in healthy patients or as a compromise in less fit patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung cancer study group. Ann Thorac Surg. 1995;60(3):615–22. discussion 22–3

    CAS  PubMed  Google Scholar 

  2. Altorki NK, Wang X, Wigle D, Gu L, Darling G, Ashrafi AS, et al. Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503). Lancet Respir Med. 2018;6(12):915–24.

    PubMed  PubMed Central  Google Scholar 

  3. Suzuki K, Saji H, Aokage K, Watanabe SI, Okada M, Mizusawa J, et al. Comparison of pulmonary segmentectomy and lobectomy: safety results of a randomized trial. J Thorac Cardiovasc Surg. 2019;158(3):895–907.

    PubMed  Google Scholar 

  4. Stamatis G, Leschber G, Schwarz B, Brintrup DL, Ose C, Weinreich G, et al. Perioperative course and quality of life in a prospective randomized multicenter phase III trial, comparing standard lobectomy versus anatomical segmentectomy in patients with non-small cell lung cancer up to 2 cm, stage IA (7th edition of TNM staging system). Lung Cancer. 2019;138:19–26.

    PubMed  Google Scholar 

  5. Detterbeck FC, Mase VJ, Jr., Li AX, Kumbasar U, Bade BC, Park HS, et al. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation. Part 2: evidence regarding resection extent in generally healthy patients. J Thorac Dis. 2022;14(6):2357–86.

    Google Scholar 

  6. Linden PA, D’Amico TA, Perry Y, Saha-Chaudhuri P, Sheng S, Kim S, et al. Quantifying the safety benefits of wedge resection: a society of thoracic surgery database propensity-matched analysis. Ann Thorac Surg. 2014;98(5):1705–11. discussion 11–2

    PubMed  Google Scholar 

  7. Stokes WA, Bronsert MR, Meguid RA, Blum MG, Jones BL, Koshy M, et al. Post-treatment mortality after surgery and stereotactic body radiotherapy for early-stage non-small-cell lung cancer. J Clin Oncol. 2018;36(7):642–51.

    PubMed  Google Scholar 

  8. Zhang Z, Feng H, Zhao H, Hu J, Liu L, Liu Y, et al. Sublobar resection is associated with better perioperative outcomes in elderly patients with clinical stage I non-small cell lung cancer: a multicenter retrospective cohort study. J Thorac Dis. 2019;11(5):1838–48.

    PubMed  PubMed Central  Google Scholar 

  9. Khullar OV, Liu Y, Gillespie T, Higgins KA, Ramalingam S, Lipscomb J, et al. Survival after sublobar resection versus lobectomy for clinical stage IA lung cancer: an analysis from the National Cancer Data Base. J Thorac Oncol. 2015;10(11):1625–33.

    PubMed  PubMed Central  Google Scholar 

  10. Shirvani SM, Jiang J, Chang JY, Welsh J, Likhacheva A, Buchholz TA, et al. Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly. JAMA Surg. 2014;149(12):1244–53.

    PubMed  PubMed Central  Google Scholar 

  11. Bédat B, Abdelnour-Berchtold E, Perneger T, Licker MJ, Stefani A, Krull M, et al. Comparison of postoperative complications between segmentectomy and lobectomy by video-assisted thoracic surgery: a multicenter study. J Cardiothorac Surg. 2019;14(1):189.

    PubMed  PubMed Central  Google Scholar 

  12. Schwartz RM, Yip R, Flores RM, Olkin I, Taioli E, Henschke C. The impact of resection method and patient factors on quality of life among stage IA non-small cell lung cancer surgical patients. J Surg Oncol. 2017;115(2):173–80.

    PubMed  Google Scholar 

  13. Schwartz RM, Yip R, Olkin I, Sikavi D, Taioli E, Henschke C. Impact of surgery for stage IA non-small-cell lung cancer on patient quality of life. J Community Support Oncol. 2016;14(1):37–44.

    CAS  PubMed  Google Scholar 

  14. Mase VJ Jr, Detterbeck FC. Approach to the subsolid nodule. Clin Chest Med. 2020;41(1):99–113.

    PubMed  Google Scholar 

  15. Kobayashi Y, Fukui T, Ito S, Usami N, Hatooka S, Yatabe Y, et al. How long should small lung lesions of ground-glass opacity be followed? J Thorac Oncol. 2013;8(3):309–14.

    PubMed  Google Scholar 

  16. Yatabe Y, Borczuk AC, Powell CA. Do all lung adenocarcinomas follow a stepwise progression? Lung Cancer. 2011;74(1):7–11.

    PubMed  Google Scholar 

  17. Sawada S, Yamashita N, Sugimoto R, Ueno T, Yamashita M. Long-term outcomes of patients with ground-glass opacities detected using computed tomography. Chest. 2017;151(2):308–15.

    PubMed  Google Scholar 

  18. Kakinuma R, Noguchi M, Ashizawa K, Kuriyama K, Maeshima AM, Koizumi N, et al. Natural history of pulmonary subsolid nodules: a prospective multicenter study. J Thorac Oncol. 2016;11(7):1012–28.

    PubMed  Google Scholar 

  19. Saji H, Okada M, Tsuboi M, Nakajima R, Suzuki K, Aokage K, et al. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet 2022;399:1607–17.

    Google Scholar 

  20. Bade BC, Blasberg JD, Mase VJ Jr, Kumbasar U, Li AX, Park HS, et al. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation. Part 3: evidence regarding surgery in compromised patients or specific tumors. J Thorac Dis. 2022;14(6):2387–411.

    Google Scholar 

  21. Altorki NK, Yip R, Hanaoka T, Bauer T, Aye R, Kohman L, et al. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules. J Thorac Cardiovasc Surg. 2014;147(2):754–62. Discussion 62–4.

    PubMed  Google Scholar 

  22. Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M, et al. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study. J Thorac Cardiovasc Surg. 2013;146(2):358–64.

    PubMed  Google Scholar 

  23. Zhang C, He Z, Cheng J, Cao J, Hu J. Surgical outcomes of lobectomy versus limited resection for clinical stage I ground-glass opacity lung adenocarcinoma 2 centimeters or smaller. Clin Lung Cancer. 2020;22(2):e160–8. https://doi.org/10.1016/j.cllc.2020.09.022.

    Article  PubMed  Google Scholar 

  24. Kodama K, Higashiyama M, Okami J, Tokunaga T, Imamura F, Nakayama T, et al. Oncologic outcomes of segmentectomy versus lobectomy for clinical T1a N0 M0 non-small cell lung cancer. Ann Thorac Surg. 2016;101(2):504–11.

    PubMed  Google Scholar 

  25. Chiang XH, Hsu HH, Hsieh MS, Chang CH, Tsai TM, Liao HC, et al. Propensity-matched analysis comparing survival after sublobar resection and lobectomy for cT1N0 lung adenocarcinoma. Ann Surg Oncol. 2020;27(3):703–15.

    PubMed  Google Scholar 

  26. Okada M, Mimae T, Tsutani Y, Nakayama H, Okumura S, Yoshimura M, et al. Segmentectomy versus lobectomy for clinical stage IA lung adenocarcinoma. Ann Cardiothorac Surg. 2014;3(2):153–9.

    PubMed  PubMed Central  Google Scholar 

  27. Hwang Y, Kang CH, Kim HS, Jeon JH, Park IK, Kim YT. Comparison of thoracoscopic segmentectomy and thoracoscopic lobectomy on the patients with non-small cell lung cancer: a propensity score matching study. Eur J Cardiothorac Surg. 2015;48(2):273–8.

    PubMed  Google Scholar 

  28. Suzuki K, Watanabe S, Wakabayashi M, Yasumitsu M, Yoshino I, Tsuboi M, et al., editors. A nonrandomized confirmatory phase III study of sublobar surgical resection for peripheral ground glass opacity dominant lung cancer defined with thoracic thin-section computed tomography. Chicago, IL: ASCO; 2017.

    Google Scholar 

  29. Nakao M, Yoshida J, Goto K, Ishii G, Kawase A, Aokage K, et al. Long-term outcomes of 50 cases of limited-resection trial for pulmonary ground-glass opacity nodules. J Thorac Oncol. 2012;7(10):1563–6.

    PubMed  Google Scholar 

  30. Altorki NK, Wang X, Kozono D, Watt C, Landreneau R, Wigle D, et al. Lobar or sub-lobar resection for peripheral clinical stage IA = 2 cm non-small cell lung cancer (NSCLC): Results from an international randomized phase iii trial (CALGB 140503 [Alliance]). Plenary Session, World Conference on Lung Cancer, Vienna Austria. 2022

    Google Scholar 

  31. Ezer N, Kale M, Sigel K, Lakha S, Mhango G, Goodman E, et al. Outcomes after video-assisted thoracoscopic lobectomy versus open lobectomy for early-stage lung cancer in older adults. Ann Am Thorac Soc. 2018;15(1):76–82.

    PubMed  PubMed Central  Google Scholar 

  32. Smith CB, Kale M, Mhango G, Neugut AI, Hershman DL, Mandeli JP, et al. Comparative outcomes of elderly stage I lung cancer patients treated with segmentectomy via video-assisted thoracoscopic surgery versus open resection. J Thorac Oncol. 2014;9(3):383–9.

    PubMed  Google Scholar 

  33. Zhang Y, Yuan C, Zhang Y, Sun Y, Chen H. Survival following segmentectomy or lobectomy in elderly patients with early-stage lung cancer. Oncotarget. 2016;7(14):19081–6.

    PubMed  PubMed Central  Google Scholar 

  34. Stiles BM, Mao J, Harrison S, Lee B, Port JL, Sedrakyan A, et al. Extent of lymphadenectomy is associated with oncological efficacy of sublobar resection for lung cancer ≤2 cm. J Thorac Cardiovasc Surg. 2019;157(6):2454–65 e1.

    PubMed  Google Scholar 

  35. Burt BM, Kosinski AS, Shrager JB, Onaitis MW, Weigel T. Thoracoscopic lobectomy is associated with acceptable morbidity and mortality in patients with predicted postoperative forced expiratory volume in 1 second or diffusing capacity for carbon monoxide less than 40% of normal. J Thorac Cardiovasc Surg. 2014;148(1):19–28. discussion −9e1

    PubMed  Google Scholar 

  36. Zhang R, Ferguson M. Video-assisted versus open lobectomy in patients with compromised lung function: a literature review and meta-analysis. PLoS One. 2015;10(7):e0124512.

    PubMed  PubMed Central  Google Scholar 

  37. Sandri A, Papagiannopoulos K, Milton R, Chaudhuri N, Kefaloyannis E, Pompili C, et al. High-risk patients and postoperative complications following video-assisted thoracic surgery lobectomy: a case-matched comparison with lower-risk counterparts dagger. Interact Cardiovasc Thorac Surg. 2015;21(6):761–5.

    PubMed  Google Scholar 

  38. Ceppa D, Kosinski A, Berry M, Tong B, Harpole D, Mitchell J. Thoracoscopic lobectomy has increasing benefit in patients with poor pulmonary function: a Society of Thoracic Surgeons database analysis. Ann Surg. 2012;256:487–93.

    PubMed  Google Scholar 

  39. Berry MF, Villamizar-Ortiz NR, Tong BC, Burfeind WR Jr, Harpole DH, D'Amico TA, et al. Pulmonary function tests do not predict pulmonary complications after thoracoscopic lobectomy. Ann Thorac Surg. 2010;89(4):1044–51. discussion 51–2

    PubMed  PubMed Central  Google Scholar 

  40. Ueda K, Tanaka T, Hayashi M, Tanaka N, Li TS, Hamano K. What proportion of lung cancers can be operated by segmentectomy? A computed-tomography-based simulation. Eur J Cardiothorac Surg. 2012;41(2):341–5.

    PubMed  Google Scholar 

  41. Mohiuddin K, Haneuse S, Sofer T, Gill R, Jaklitsch MT, Colson YL, et al. Relationship between margin distance and local recurrence among patients undergoing wedge resection for small (≤2 cm) non-small cell lung cancer. J Thorac Cardiovasc Surg. 2014;147(4):1169–75. discussion 75–7.

    PubMed  Google Scholar 

  42. Maurizi G, D'Andrilli A, Ciccone AM, Ibrahim M, Andreetti C, Tierno S, et al. Margin distance does not influence recurrence and survival after wedge resection for lung cancer. Ann Thorac Surg. 2015;100(3):918–24. discussion 24–5

    PubMed  Google Scholar 

  43. Moon Y, Lee KY, Moon SW, Park JK. Sublobar resection margin width does not affect recurrence of clinical N0 non-small cell lung cancer presenting as GGO-predominant nodule of 3 cm or less. World J Surg. 2017;41(2):472–9.

    PubMed  Google Scholar 

  44. El-Sherif A, Fernando H, Santos R, Pettiford B, Luketich J, Close J, et al. Margin and local recurrence after sublobar resection of non-small cell lung cancer. Ann Surg Oncol. 2007;14(8):2400–5.

    PubMed  Google Scholar 

  45. Wolf AS, Swanson SJ, Yip R, Liu B, Tarras ES, Yankelevitz DF, et al. The impact of margins on outcomes after wedge resection for stage I non-small cell lung cancer. Ann Thorac Surg. 2017;104(4):1171–8.

    PubMed  Google Scholar 

  46. Masai K, Sakurai H, Sukeda A, Suzuki S, Asakura K, Nakagawa K, et al. Prognostic impact of margin distance and tumor spread through air spaces in limited resection for primary lung cancer. J Thorac Oncol. 2017;12(12):1788–97.

    PubMed  Google Scholar 

  47. Sawabata N, Maeda H, Matsumura A, Ohta M, Okumura M. Clinical implications of the margin cytology findings and margin/tumor size ratio in patients who underwent pulmonary excision for peripheral non-small cell lung cancer. Surg Today. 2012;42(3):238–44.

    PubMed  Google Scholar 

  48. Takahashi N, Sawabata N, Kawamura M, Ohtsuka T, Horio H, Sakaguchi H, et al. Optimal sublobar resection for c-stage I non-small cell lung cancer: significance of margin distance to tumor size ratio and margin cytology (supplementary analysis of KLSG-0801): complete republication. Gen Thorac Cardiovasc Surg. 2019;67(8):690–6.

    PubMed  Google Scholar 

  49. Fernando H, Landreneau R, Mandrekar S, Nichols F III, Hillman S, Heron D, et al. Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small cell lung cancer (NSCLC). J Clin Oncol. 2014;32(23):2456–62.

    PubMed  PubMed Central  Google Scholar 

  50. Moon Y, Lee KY, Park JK. Margin width of resected lepidic lung cancer does not affect recurrence after sublobar resection. World J Surg. 2018;42(5):1449–57.

    PubMed  Google Scholar 

  51. Moon Y, Park JK, Lee KY. The effect of resection margin distance and invasive component size on recurrence after sublobar resection in patients with small (≤2 cm) lung adenocarcinoma. World J Surg. 2020;44(3):990–7.

    PubMed  Google Scholar 

  52. Schuchert MJ, Pettiford BL, Keeley S, D’Amato TA, Kilic A, Close J, et al. Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer. Ann Thorac Surg. 2007;84(3):926–33.

    PubMed  Google Scholar 

  53. Eguchi T, Kameda K, Lu S, Bott MJ, Tan KS, Montecalvo J, et al. Lobectomy is associated with better outcomes than sublobar resection in Spread Through Air Spaces (STAS)-positive T1 lung adenocarcinoma: a propensity score-matched analysis. J Thorac Oncol. 2019;14(1):87–98.

    PubMed  Google Scholar 

  54. Ren Y, Xie H, Dai C, She Y, Su H, Xie D, et al. Prognostic impact of tumor spread through air spaces in sublobar resection for 1A lung adenocarcinoma patients. Ann Surg Oncol. 2019;26(6):1901–8.

    PubMed  Google Scholar 

  55. Kadota K, Nitadori J-i, Sima CS, Ujiie H, Rizk NP, Jones DR, et al. Tumor spread through air spaces is an important pattern of invasion and impacts the frequency and location of recurrences after limited resection for small stage I lung adenocarcinomas. J Thor Oncol. 2015;10(5):806–14.

    CAS  Google Scholar 

  56. Yanagawa N, Shiono S, Endo M, Ogata SY. Tumor spread through air spaces is a useful predictor of recurrence and prognosis in stage I lung squamous cell carcinoma, but not in stage II and III. Lung Cancer. 2018;120:14–21.

    PubMed  Google Scholar 

  57. Jia M, Yu S, Gao H, Sun PL. Spread Through Air Spaces (STAS) in lung cancer: a multiple-perspective and update review. Cancer Manag Res. 2020;12:2743–52.

    CAS  PubMed  PubMed Central  Google Scholar 

  58. Chen D, Mao Y, Wen J, She Y, Zhu E, Zhu F, et al. Tumor spread through air spaces in non-small cell lung cancer: a systematic review and meta-analysis. Ann Thorac Surg. 2019;108(3):945–54.

    PubMed  Google Scholar 

  59. Kadota K, Kushida Y, Katsuki N, Ishikawa R, Ibuki E, Motoyama M, et al. Tumor spread through air spaces is an independent predictor of recurrence-free survival in patients with resected lung squamous cell carcinoma. Am J Surg Pathol. 2017;41(8):1077–86.

    PubMed  Google Scholar 

  60. Shiono S, Endo M, Suzuki K, Yarimizu K, Hayasaka K, Yanagawa N. Spread through air spaces is a prognostic factor in sublobar resection of non-small cell lung cancer. Ann Thorac Surg. 2018;106(2):354–60.

    PubMed  Google Scholar 

  61. Uruga H, Fujii T, Fujimori S, Kohno T, Kishi K. Semiquantitative assessment of tumor Spread Through Air Spaces (STAS) in early-stage lung adenocarcinomas. J Thorac Oncol. 2017;12(7):1046–51.

    PubMed  Google Scholar 

  62. Toyokawa G, Yamada Y, Tagawa T, Kozuma Y, Matsubara T, Haratake N, et al. Significance of spread through air spaces in resected pathological stage I lung adenocarcinoma. Ann Thorac Surg. 2018;105(6):1655–63.

    PubMed  Google Scholar 

  63. Toyokawa G, Yamada Y, Tagawa T, Oda Y. Significance of spread through air spaces in early-stage lung adenocarcinomas undergoing limited resection. Thorac Cancer. 2018;9(10):1255–61.

    PubMed  PubMed Central  Google Scholar 

  64. Shiono S, Endo M, Suzuki K, Yanagawa N. Spread through air spaces affects survival and recurrence of patients with clinical stage IA non-small cell lung cancer after wedge resection. J Thorac Dis. 2020;12(5):2247–60.

    PubMed  PubMed Central  Google Scholar 

  65. Kadota K, Kushida Y, Kagawa S, Ishikawa R, Ibuki E, Inoue K, et al. Limited resection is associated with a higher risk of locoregional recurrence than lobectomy in stage I lung adenocarcinoma with tumor spread through air spaces. Am J Surg Pathol. 2019;43(8):1033–41.

    PubMed  Google Scholar 

  66. Han YB, Kim H, Mino-Kenudson M, Cho S, Kwon HJ, Lee KR, et al. Tumor Spread Through Air Spaces (STAS): prognostic significance of grading in non-small cell lung cancer. Mod Pathol. 2021;34(3):549–61.

    PubMed  Google Scholar 

  67. Kagimoto A, Tsutani Y, Kushitani K, Kai Y, Kambara T, Miyata Y, et al. Segmentectomy vs. lobectomy for clinical stage IA lung adenocarcinoma with spread through air spaces. Ann Thorac Surg. 2021;112:935–43.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Thoracic Surgery, Yale University School of Medicine, New Haven, CT, USA

    Ulas Kumbasar & Frank C. Detterbeck

Authors
  1. Ulas Kumbasar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Frank C. Detterbeck
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Frank C. Detterbeck .

Editor information

Editors and Affiliations

  1. Hospital General Universitario Dr. Balmis de Alicante, Alicante, Spain

    Carlos Galvez  & Sergio Bolufer  & 

  2. Thoracic Surgery Dept., Hosp. Clínico Universitario de Valencia, Valencia, Spain

    Santiago Figueroa

  3. Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain

    Andrés Obeso

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Cite this chapter

Kumbasar, U., Detterbeck, F.C. (2023). Indications for Sublobar Resection in the Treatment of Non-Small Cell Lung Cancer (NSCLC). In: Galvez, C., Bolufer, S., Figueroa, S., Obeso, A. (eds) Video-Atlas of VATS Pulmonary Sublobar Resections. Springer, Cham. https://doi.org/10.1007/978-3-031-14455-4_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-14455-4_1

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-14454-7

  • Online ISBN: 978-3-031-14455-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation